Compton Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,585
| Closed | -$853K | – | 32 |
|
|
2023
Q1 | $853K | Sell |
10,585
-38,007
| -78% | -$3.1M | 1.84% | 14 |
|
|
2022
Q4 | $3.78M | Buy |
48,592
+21,336
| +78% | +$1.73M | 2.72% | 9 |
|
|
2022
Q3 | $2.2M | Sell |
27,256
-216
| -0.8% | -$19.4K | 1.47% | 20 |
|
|
2022
Q2 | $2.47M | Sell |
27,472
-348
| -1% | -$35.3K | 1.36% | 25 |
|
|
2022
Q1 | $3.09M | Buy |
27,820
+50
| +0.2% | +$5.28K | 0.86% | 31 |
|
|
2021
Q4 | $2.87M | Buy |
27,770
+75
| +0.3% | +$8.69K | 0.75% | 36 |
|
|
2021
Q3 | $3.47M | Sell |
27,695
-325
| -1% | -$42.1K | 1.02% | 23 |
|
|
2021
Q2 | $3.48M | Hold |
28,020
| – | – | 1.02% | 23 |
|
|
2021
Q1 | $3.31M | Sell |
28,020
-125
| -0.4% | -$14.7K | 1.04% | 25 |
|
|
2020
Q4 | $3.3M | Hold |
28,145
| – | – | 1.12% | 25 |
|
|
2020
Q3 | $2.92M | Buy |
28,145
+250
| +0.9% | +$25.1K | 1.12% | 23 |
|
|
2020
Q2 | $2.56M | Hold |
27,895
| – | – | 1.07% | 28 |
|
|
2020
Q1 | $2.52M | Buy |
27,895
+85
| +0.3% | +$9.04K | 1.24% | 25 |
|
|
2019
Q4 | $3.15M | Buy |
27,810
+50
| +0.2% | +$5.49K | 1.22% | 23 |
|
|
2019
Q3 | $3.02M | Sell |
27,760
-391
| -1% | -$40.8K | 1.27% | 21 |
|
|
2019
Q2 | $2.74M | Buy |
28,151
+329
| +1% | +$30K | 1.16% | 28 |
|
|
2019
Q1 | $2.53M | Sell |
27,822
-50
| -0.2% | -$4.47K | 1.1% | 30 |
|
|
2018
Q4 | $2.54M | Sell |
27,872
-600
| -2% | -$56.1K | 1.21% | 23 |
|
|
2018
Q3 | $2.8M | Sell |
28,472
-200
| -0.7% | -$18.5K | 1.11% | 25 |
|
|
2018
Q2 | $2.46M | Sell |
28,672
-140
| -0.5% | -$11.7K | 1.04% | 30 |
|
|
2018
Q1 | $2.31M | Sell |
28,812
-70
| -0.2% | -$5.77K | 0.98% | 35 |
|
|
2017
Q4 | $2.33M | Sell |
28,882
-100
| -0.3% | -$8.01K | 1% | 32 |
|
|
2017
Q3 | $2.25M | Sell |
28,982
-1,535
| -5% | -$127K | 1.01% | 33 |
|
|
2017
Q2 | $2.71M | Buy |
30,517
+270
| +0.9% | +$22.8K | 1.23% | 22 |
|
|
2017
Q1 | $2.44M | Buy |
30,247
+254
| +0.8% | +$19.8K | 1.2% | 23 |
|
|
2016
Q4 | $2.14M | Sell |
29,993
-24,853
| -45% | -$1.95M | 1.12% | 28 |
|
|
2016
Q3 | $4.75M | Buy |
54,846
+27,448
| +100% | +$2.39M | 1.31% | 22 |
|
|
2016
Q2 | $2.38M | Sell |
27,398
-403
| -1% | -$32.6K | 1.33% | 21 |
|
|
2016
Q1 | $2.08M | Buy |
27,801
+464
| +2% | +$34.9K | 1.17% | 27 |
|
|
2015
Q4 | $2.1M | Sell |
27,337
-39
| -0.1% | -$2.94K | 1.19% | 24 |
|
|
2015
Q3 | $1.83M | Sell |
27,376
-1,122
| -4% | -$82.6K | 0.66% | 26 |
|
|
2015
Q2 | $2.11M | Buy |
28,498
+100
| +0.4% | +$7.64K | 1.16% | 26 |
|
|
2015
Q1 | $2.21M | Buy |
28,398
+14,893
| +110% | +$1.13M | 1.23% | 24 |
|
|
2014
Q4 | $975K | Sell |
13,505
-700
| -5% | -$48.6K | 0.53% | 55 |
|
|
2014
Q3 | $880K | Buy |
14,205
+50
| +0.4% | +$3.18K | 0.48% | 60 |
|
|
2014
Q2 | $903K | Buy |
14,155
+8,150
| +136% | +$495K | 0.49% | 62 |
|
|
2014
Q1 | $370K | Buy |
6,005
+500
| +9% | +$29.1K | 0.21% | 100 |
|
|
2013
Q4 | $316K | Hold |
5,505
| – | – | 0.18% | 107 |
|
|
2013
Q3 | $293K | Sell |
5,505
-200
| -4% | -$10.8K | 0.18% | 111 |
|
|
2013
Q2 | $294K | Buy |
+5,705
| New | +$282K | 0.18% | 108 |
|
Other funds holding MDT
Compton Capital Management's MDT Position: Q2 2023 in Review
Compton Capital Management sold out of Medtronic (MDT) in Q2 2023, closing a stake of 10,585 shares — an estimated $853K sold.
Compton Capital Management first reported a position in MDT in Q2 2013 and held it in 40 quarters. The position peaked at $4.75M in Q3 2016. 2,057 funds tracked by Wall St. Rank hold MDT as of Q2 2023.
- Compton Capital Management reported no remaining Medtronic position as of Q2 2023 after selling out during the quarter.
- Compton Capital Management sold 10,585 Medtronic shares in Q2 2023, an estimated $853K.
- Compton Capital Management first reported a position in Medtronic in Q2 2013 and held it in 40 quarters.
- Compton Capital Management's Medtronic position peaked at $4.75M in Q3 2016.
- 2,057 funds tracked by Wall St. Rank held Medtronic as of Q2 2023.
Based on Compton Capital Management's 13F filing for Q2 2023, filed 9 Aug 2023.